Enhancing the satisfaction with prostate cancer treatment decision with the mHealth progam PROSTANA®: A multicenter randomized controlled trial

Enhancing the satisfaction with prostate cancer treatment decision with the mHealth progam PROSTANA®: A multicenter randomized controlled trial - EasiPRO3

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00024555

Enrollment

412

Registered

2021-03-04

Start date

2017-12-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C61

Interventions

Group 1: Intervention group: Patients who are treated with the intervention PROSTANA®, as well as their urologists and optional their relatives, receive a questionnaire at four different dates Group 2

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Minimum age of 18 years - Patients in the participating centers - Initial diagnosis of PCa (ICD-10 code C61) - Access to internet-enabled devices - Classified by physician as capable of participating in the study - Existing participation forms

Exclusion criteria

Exclusion criteria: - Under 18 years - Patients who are already in treatment - Patients for whom the treatment of a comorbidity is absolutely paramount on basis of the treating urologist

Design outcomes

Primary

Measure	Time frame
Satisfaction with Decision (SWD-Scale)	—

Secondary

Measure	Time frame
- Psychological Burden (HADS-D) - Decisional Conflict (DCS-D) - Shared Decision Making (SDM)	—

Countries

Germany

Contacts

Public ContactPeter Kollenbach

Urologie Weinbergstraße

kollenbach-uro@t-online.de0561 8104190

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026